Cargando…

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist

Synthetic cannabinoid receptor agonists (SCRAs) are the largest class of new psychoactive substances (NPS). New examples are detected constantly, and some are associated with a series of adverse effects, including seizures. CUMYL-4CN-BINACA (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kevin, Richard C., Anderson, Lyndsey, McGregor, Iain S., Boyd, Rochelle, Manning, Jamie J., Glass, Michelle, Connor, Mark, Banister, Samuel D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549035/ https://www.ncbi.nlm.nih.gov/pubmed/31191320 http://dx.doi.org/10.3389/fphar.2019.00595

Ejemplares similares

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11
por: Kevin, Richard C., et al.
Publicado: (2022)

In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA
por: Kevin, Richard C., et al.
Publicado: (2017)

Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs
por: Sparkes, Eric, et al.
Publicado: (2022)

Phase I In Vitro Metabolic Profiling of the Synthetic Cannabinoid Receptor Agonists CUMYL-THPINACA and ADAMANTYL-THPINACA
por: Monti, Manuela Carla, et al.
Publicado: (2021)

Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE
por: Mogler, Lukas, et al.
Publicado: (2018)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA
por: Angerer, Verena, et al.
Publicado: (2018)

Induction of Liver Size Reduction in Zebrafish Larvae by the Emerging Synthetic Cannabinoid 4F-MDMB-BINACA and Its Impact on Drug Metabolism
por: Park, Yu Mi, et al.
Publicado: (2022)

Differential activation of G protein‐mediated signaling by synthetic cannabinoid receptor agonists
por: Sachdev, Shivani, et al.
Publicado: (2020)

Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA—parent compounds and metabolite identification in blood, urine and cerebrospinal fluid
por: Tokarczyk, Bogdan, et al.
Publicado: (2022)

Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome
por: Anderson, Lyndsey L., et al.
Publicado: (2022)

The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients
por: Jackson, Melissa A., et al.
Publicado: (2021)

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy
por: Harman, Thomas, et al.
Publicado: (2023)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Simultaneous fatal poisoning of two victims with 4F-MDMB-BINACA and ethanol
por: Simon, Gábor, et al.
Publicado: (2022)

Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
por: Gavryushov, Sergei, et al.
Publicado: (2023)

An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma
por: Colvin, Emily K., et al.
Publicado: (2022)

Synthetic Cannabinoid Receptor Agonists Detection Using Fluorescence Spectral Fingerprinting
por: May, Benedict, et al.
Publicado: (2019)

Influence of the Synthetic Cannabinoid Agonist on Normal and Inflamed Cartilage: An In Vitro Study
por: Shang, Jiangyinzi, et al.
Publicado: (2023)

The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities
por: Longworth, Mitchell, et al.
Publicado: (2016)

In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist
por: Burstein, Sumner H, et al.
Publicado: (2013)

Fourth generation of synthetic cannabinoid receptor agonists: a summary on the latest insights
por: Malaca, Sara, et al.
Publicado: (2021)

Synthetic cannabinoids
por: Bilici, Rabia
Publicado: (2014)

The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists
por: Fuchs, Alexander, et al.
Publicado: (2013)

Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
por: Zagzoog, Ayat, et al.
Publicado: (2021)

A nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel function
por: Milligan, Carol J., et al.
Publicado: (2022)

Development of Cross-Reactive Antibodies for the Identification and Treatment of Synthetic Cannabinoid Receptor Agonist Toxicity
por: Worob, Adam, et al.
Publicado: (2022)

Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists
por: Pandey, Pankaj, et al.
Publicado: (2018)

Assessment of the Abuse Liability of Synthetic Cannabinoid Agonists JWH-030, JWH-175, and JWH-176
por: Tampus, Reinholdgher, et al.
Publicado: (2015)

Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
por: Swift, Wendy, et al.
Publicado: (2013)

Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances
por: Qian, Zhenhua, et al.
Publicado: (2015)

Febrile Convulsions
por: Clarke, Patrick, et al.
Publicado: (1967)

Cannabinoid antagonist SLV326 induces convulsive seizures and changes in the interictal EEG in rats
por: Perescis, Martin F. J., et al.
Publicado: (2017)

Effectiveness of the synthetic cannabinoids seminar
por: Seyit, Murat, et al.
Publicado: (2016)

Synthetic cannabinoids and renal injury
por: Alp, Alper
Publicado: (2015)

Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists
por: Giorgetti, Arianna, et al.
Publicado: (2020)

Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis
por: Craft, Sam, et al.
Publicado: (2021)

A new highly active La(2)O(3)–CuO–MgO catalyst for the synthesis of cumyl peroxide by catalytic oxidation
por: Liu, HanShuang, et al.
Publicado: (2021)

Behavioral and Molecular Responses to Exogenous Cannabinoids During Pentylenetetrazol-Induced Convulsions in Male and Female Rats
por: Zirotti Rosenberg, Antonella, et al.
Publicado: (2022)

Evaluation of carboxamide-type synthetic cannabinoids as CB(1)/CB(2) receptor agonists: difference between the enantiomers
por: Doi, Takahiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c94384dhldq391mnnqivg8gra9